English | Español

Pfizer
+ Technology/Innovation
Robert Hadley | Jun 23, 2017

Pfizer clinical trial seeks Group B Streptococcus vaccine 
+ Regulatory
Robert Hadley | Jun 22, 2017

Phase 3 trial of Pfizer’s prostate cancer drug could yield results two years early
+ Technology/Innovation
Ruth de Jauregui | May 18, 2017

Smartphone app for lupus patients to be tested
+ Technology/Innovation
Cheyenne Dickerson | May 14, 2017

Smartphone app allows lupus patients to track symptoms
+ Technology/Innovation
Robert Hadley | Apr 28, 2017

Trial indicates new Pfizer drug battles hospital-grade pneumonia
Robert Hadley | Apr 18, 2017

FDA approves Pfizer's Ibrance for use in breast cancer treatment
+ Regulatory
Robert Hadley | Apr 5, 2017

European Commission OKs Pfizer’s Xeljanz for rheumatoid arthritis treatment
Robert Hadley | Apr 5, 2017

Immunotherapy drug approved for U.S. patients

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes